Disease State Resource
Dendreon offers healthcare professionals in the United States disease state resources to aid informed clinical and treatment decisions.
Dendreon offers healthcare professionals in the United States disease state resources to aid informed clinical and treatment decisions.
COVID-19 Update
At Dendreon Pharmaceuticals LLC, the health and well-being of our employees, patients, and communities are of high importance.
Our priority remains serving the needs of our patients, healthcare professionals, and our community. During these unprecedented times, Dendreon manufacturing facilities remain open and operational. As an added precautionary measure, Dendreon has limited manufacturing facility access to essential personnel only. This preserves our ability to continue serving healthcare professionals and patients, while protecting the health of our employees.
We are currently unaware of any logistical issues related to the manufacture of PROVENGE® (sipuleucel-T). For up‐to‐date information, please contact Dendreon On Call at (877) 336-3736 and select option #2.
Many of the apheresis collection centers, which are operated independently of Dendreon, are taking additional measures to maintain patient safety in response to COVID‐19, including travel‐related recommendations and pre‐screening calls to assess patients’ health. The reasons for these efforts are to minimize the number of patients unable to undergo leukapheresis and to keep every apheresis center as safe as possible for patients and staff. Please reach out to your apheresis collection center for additional information.
Dendreon will continue to monitor and assess the COVID-19 situation in the United States and will update this notice as necessary. For further information, please send your requests to MAC@dendreon.com
You are now leaving the Dendreon Medical Affairs site
Dendreon provides this link as a service to website visitors. Dendreon is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click CANCEL to return to our website or OK to continue.
You are now leaving DendreonMedicalAffairs.com
You are about to enter another Dendreon-affiliated property.
Click CANCEL to return to our website or OK to continue.
REQUEST SUBMITTED
Thank you for your interest in the CME & Grant Requests program. A member of the Medical Affairs team has been assigned this case. Our Program Review Committee will respond within 30 business days. For a more immediate response, please email medicalgrantrequests@dendreon.com.
Terms of Use
Welcome to Dendreon Medical Affairs.
The information available on this site is for healthcare professionals practicing within the United States in need of trusted clinical and scientific information on our product. Medical information available through this website is not medical advice, and patient care remains the ultimate responsibility of the licensed health care professional.
Dendreon does not recommend the use of its products in any manner inconsistent with the FDA-approved Prescribing Information. In the United States, please refer to the full Prescribing Information for approved indication and Important Safety Information.
Are you a healthcare professional practicing in the United States?
THANK YOU
Thank you for your request for medical information. A member of the Medical Affairs team has been assigned this case. Our response times are typically within 48 to 72 hours. However, timing may depend on the nature of the information requested and the need to obtain input from subject matter experts within the company.